Bangalore, India -- (SBWire) -- 02/09/2018 --Influenza is an infectious disease caused by the influenza virus. It is also known as flu. Influenza virus is a ribonucleic acid (RNA) virus that belongs to Orthomyxoviridae family. It is a helical shaped, single-stranded virus. Influenza A virus affects people of all age groups and causes moderate to severe illness, while the infection due to influenza B virus results in milder disease and affects pediatrics primarily.
Human illness due to influenza C is rare. Influenza C illness might be due to subclinical cases. Hence, it does not cause epidemic diseases. Influenza has emerged as a severe health concern globally. The market encompasses both live attenuated as well as recombinant influenza vaccines for the prevention of influenza. The major factors that lead to the market growth include the need for annual vaccination and government initiatives to improve awareness about vaccination.
Report forecast the global influenza vaccine market to grow at a CAGR of 7.23% during the period 2018-2022.
The report covers the present scenario and the growth prospects of the global influenza vaccine market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of influenza vaccine.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
Global Influenza Vaccine Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
- AstraZeneca
- CSL
- GlaxoSmithKline
- Sanofi
Other prominent vendors
- Altimmune
- BionVax
- FluGen
- FOLIA BIOTECH
- Genentech
- Green Cross
- Medicago
- Moderna Therapeutics
- Novavax
- Shijiazhuang Yiling Pharmaceutical
- SK Chemicals
- UNM Pharma
- Vaccitech
- Vaxart
- Vaxine Pty
- Visterra.
Market driver
- Rising awareness about influenza vaccination
- For a full, detailed list, view our report
Market trend
- Development of strong pipeline
- For a full, detailed list, view our report
Key questions answered in this report
- What will the market size be in 2022 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
Spanning over 113 pages "Global Influenza Vaccine Market 2018 - 2022" report covers Executive Summary, Scope Of The Report, Research Methodology, Introduction, Market Landscape, Market Sizing, Five Forces Analysis, Pipeline Landscape, Market Segmentation By Vaccine Type, Market Segmentation By Age Group, Customer Landscape, Regional Landscape, Decision Framework, Drivers And Challenges, Market Trends, Vendor Landscape, Vendor Analysis, Appendix.
For more information Visit at: https://www.drugpipeline.net/technavio/global-influenza-vaccine-market-2018-2022
Find all Pharma and Healthcare Reports at - http://www.drugpipeline.net/catalog/pharma-healthcare
Related Reports;
Global Sexually Transmitted Diseases Testing Market 2018-2022 - Visit at - https://www.drugpipeline.net/technavio/global-sexually-transmitted-diseases-testing-market-2018-2022
Global Nursing Breast Pads Market 2018-2022 - Visit at - https://www.drugpipeline.net/technavio/global-nursing-breast-pads-market-2018-2022
About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.
Global Influenza Vaccine Market 2018 - 2022; New Report Launched
DrugPipeline.net has announced the addition of “Global Influenza Vaccine Market 2018 - 2022” research report to their website www.DrugPipeline.net